Similarly, type X collagen (Col10a1) was significantly up-regulated with BMP6 treatment (n = 6, p < 0.0001), and compared to d0 samples expression decreased in control OM MMs and increased in BMP6-treated MMs (Fig. 8A). Here, COL10A1 is linked to ocular melanoma.